Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study - Long, Yin; Zhang, Shangzhu; Zhao, Jiuliang; You, Hanxiao; Zhang, Li; Li, Jing; Leng, Xiaomei; Wang, Qian; Tian, Xinping; Li, Mengtao; Zeng, Xiaofeng (Lupus, 2021)
Keywords: Adolescent; Adult; Antibodies, Antiphospholipid - blood; Antiphospholipid antibodies; Antirheumatic Agents - therapeutic use; Arthritis; Central nervous system; China - epidemiology; Cohort analysis; Cohort Studies; Female; Femur; Femur Head Necrosis - blood; Femur Head Necrosis - epidemiology; Femur Head Necrosis - etiology; Glucocorticoids; Glucocorticoids - adverse effects; Glucocorticoids - therapeutic use; Humans; Hydroxychloroquine; Hydroxychloroquine - therapeutic use; Lupus; Lupus Erythematosus, Systemic - blood; Lupus Erythematosus, Systemic - complications; Lupus Erythematosus, Systemic - drug therapy; Lupus Erythematosus, Systemic - epidemiology; Male; Medical prognosis; Osteonecrosis; Osteonecrosis - blood; Osteonecrosis - epidemiology; Osteonecrosis - etiology; Patients; Phospholipids; Prednisolone; Prednisolone - adverse effects; Prednisolone - therapeutic use; Prevalence; Risk Factors; Survival; Systemic lupus erythematosus; Young Adult; China; anti-phospholipid antibodies; risk factors; osteonecrosis; Systemic lupus erythematosus